Literature DB >> 26756830

Hysterectomy for heavy menstrual bleeding.

Eva van der Meij1, Mark Hans Emanuel2.   

Abstract

Hysterectomy is the most frequently performed major surgical intervention in gynecology. Although surgically removing the uterus is invasive, it represents the most definitive treatment option for heavy menstrual bleeding. In this article, we will discuss the indications for hysterectomy as a treatment for heavy menstrual bleeding, the different approaches to perform the hysterectomy, the complications which may occur during and after this procedure and finally the outcomes in comparison with other treatment options.

Entities:  

Keywords:  abdominal hysterectomy; laparoscopic hysterectomy; oophorectomy; robot-assisted hysterectomy; salpingectomy; subtotal or supravaginal hysterectomy; total hysterectomy; vaginal hysterectomy

Mesh：

Year:  2016        PMID： 26756830      PMCID： PMC5779572          DOI： 10.2217/whe.15.87

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN： 1745-5057


  47 in total

1.  Outcomes after total versus subtotal abdominal hysterectomy.

Authors:  Ranee Thakar; Susan Ayers; Peter Clarkson; Stuart Stanton; Isaac Manyonda
Journal:  N Engl J Med       Date:  2002-10-24       Impact factor: 91.245

Review 2.  Risk of bladder injury during vaginal hysterectomy in women with a previous cesarean section.

Authors:  Aubert Agostini; Nadège Vejux; Emmanuelle Colette; Florence Bretelle; Ludovic Cravello; Bernard Blanc
Journal:  J Reprod Med       Date:  2005-12       Impact factor: 0.142

3.  Supravaginal uterine amputation in Denmark 1978-1988 and risk of cancer.

Authors:  H H Storm; I H Clemmensen; T Manders; L A Brinton
Journal:  Gynecol Oncol       Date:  1992-05       Impact factor: 5.482

4.  Vaginal hysterectomy following previous cesarean section.

Authors:  S S Sheth; A N Malpani
Journal:  Int J Gynaecol Obstet       Date:  1995-08       Impact factor: 3.561

Review 5.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2011-07       Impact factor: 3.466

6.  Ovarian conservation at the time of hysterectomy for benign disease.

Authors:  William H Parker; Michael S Broder; Zhimei Liu; Donna Shoupe; Cindy Farquhar; Jonathan S Berek
Journal:  Obstet Gynecol       Date:  2005-08       Impact factor: 7.661

7.  A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Minimally Invasive Surgical Techniques--Laser, EndoThermal or Endorescetion.

Authors:  C Overton; J Hargreaves; M Maresh
Journal:  Br J Obstet Gynaecol       Date:  1997-12

8.  Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate.

Authors:  J Vorwergk; M P Radosa; K Nicolaus; N Baus; J Jimenez Cruz; M Rengsberger; M Gajda; H Diebolder; I B Runnebaum
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-27       Impact factor: 4.553

9.  Vaginal hysterectomy in women with history of previous cesarean delivery.

Authors:  J B Unger; G R Meeks
Journal:  Am J Obstet Gynecol       Date:  1998-12       Impact factor: 8.661

Review 10.  Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.

Authors:  T E Roberts; A Tsourapas; L J Middleton; R Champaneria; J P Daniels; K G Cooper; S Bhattacharya; P M Barton
Journal:  BMJ       Date:  2011-04-26
View more
  2 in total

1.  Cyclical progestogens for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Low; Iain T Cameron
Journal:  Cochrane Database Syst Rev       Date:  2019-08-14

2.  Risk Factors for Impaired Patient-Reported Satisfaction and Increased Length of Hospital Stay Following Hysterectomy on Benign Indications in Premenopausal Women: a Study From the Swedish National Register for Gynecological Surgery.

Authors:  Ninnie Borendal Wodlin
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-10-23       Impact factor: 2.915
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.